Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
23.25Prev. Close
24.03Volume
909Total traded value
0.00 CrUpper Circuit
28.83Lower Circuit
19.23Fundamentals
| Market Cap | ₹12Cr |
| ROE | 6.09% |
| P/E Ratio(TTM) | 52.24 |
| EPS(TTM) | 0.46 |
| P/B Ratio | 1.29 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.62 |
| Book Value | 18.70 |
| Debt to Equity | 0.43 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Beryl Drugs
Beryl Drugs Limited is primarily engaged in the manufacturing of bulk drugs for the Indian pharmaceutical industry, enhancing medicine accessibility. Its core strategy focuses on being a customer-driven company by developing strong relationships and delivering consistent, high-quality products. Highlighting its modern approach, nearly 75% of the company's share capital is held in a secure, dematerialized (electronic) form.;
| Parent Organisation | Beryl Drugs Limited |
| BSE Symbol | 524606 |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |